Immunocompromised Host < Immunoconjugates < Immunoenzyme Techniques

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000994 (2017)	Hwiwon Lee [Corée du Sud] ; Suk Ho Bhang [Corée du Sud] ; Jeong Ho Lee [Corée du Sud] ; Hyemin Kim [Corée du Sud] ; Sei Kwang Hahn [Corée du Sud]	Tocilizumab-Alendronate Conjugate for Treatment of Rheumatoid Arthritis.
001110 (2015)	Hiroaki Takatori [Japon] ; Hirotoshi Kawashima [Japon] ; Ayako Matsuki [Japon] ; Kazuyuki Meguro [Japon] ; Shigeru Tanaka [Japon] ; Taro Iwamoto [Japon] ; Yoshie Sanayama [Japon] ; Natsuko Nishikawa [Japon] ; Tomohiro Tamachi [Japon] ; Kei Ikeda [Japon] ; Akira Suto [Japon] ; Kotaro Suzuki [Japon] ; Shin-Ichiro Kagami [Japon] ; Koichi Hirose [Japon] ; Masato Kubo [Japon] ; Shohei Hori [Japon] ; Hiroshi Nakajima [Japon]	Helios Enhances Treg Cell Function in Cooperation With FoxP3.
001231 (2014)	K. Takase [Royaume-Uni] ; S C Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; A. Mchugh [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M H Buch [Royaume-Uni]	What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
001235 (2014)	Fabrizio Cantini [Italie] ; Laura Niccoli ; Delia Goletti	Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
001276 (2014)	Ennio Giulio Favalli [Italie] ; Martina Biggioggero [Italie] ; Antonio Marchesoni [Italie] ; Pier Luigi Meroni [Italie]	Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
001300 (2014)	E. Bizzi [Oman] ; U. Massafra ; B. Laganà ; V. Bruzzese ; A Picchianti Diamanti ; M. Cassol ; A. Migliore	Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.
001303 (2014)	Claire I. Daïen [France] ; Jacques Morel [France]	Predictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.
001306 (2014)	Tamao Nakashita [Japon] ; Katsutoshi Ando [Japon] ; Norihiro Kaneko [Japon] ; Kazuhisa Takahashi [Japon] ; Shinji Motojima [Japon]	Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
001314 (2014)	Jose Ramon Maneiro [Espagne] ; Eva Perez-Pampin ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-Reino	Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.
001378 (2014)	Joaquín Borrás-Blasco [Oman] ; M Dolores-Elvira Casterá ; Xavier Cortes ; J Dolores Rosique-Robles ; F Javier Abad	Economical impact associated with a biological therapy prioritization protocol in patients with rheumatoid arthritis in the Hospital of Sagunto.
001393 (2014)	Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika Ogale	Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
001397 (2014)	Shinya Hirabara [Japon] ; Nobunori Takahashi ; Naoki Fukaya ; Hiroyuki Miyake ; Yuichiro Yabe ; Atsushi Kaneko ; Takayasu Ito ; Takeshi Oguchi ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Fumiaki Sugiura ; Masatoshi Hayashi ; Koji Funahashi ; Masahiro Hanabayashi ; Shuji Asai ; Naoki Ishiguro ; Toshihisa Kojima	Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
001398 (2014)	Nobunori Takahashi [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Yuichiro Yabe ; Hideki Takagi ; Takeshi Oguchi ; Hiroyuki Miyake ; Takefumi Kato ; Naoki Fukaya ; Hisato Ishikawa ; Masatoshi Hayashi ; Seiji Tsuboi ; Yasuhide Kanayama ; Daizo Kato ; Koji Funahashi ; Hiroyuki Matsubara ; Yosuke Hattori ; Masahiro Hanabayashi ; Shinya Hirabara ; Kenya Terabe ; Yutaka Yoshioka ; Naoki Ishiguro	Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
001426 (2014)	Sudipto Das [Royaume-Uni] ; Edward M. Vital ; Sarah Horton ; Domini Bryer ; Yasser El-Sherbiny ; Andrew C. Rawstron ; Frederique Ponchel ; Paul Emery ; Maya H. Buch	Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
001453 (2013)	Daniel E. Furst [États-Unis] ; Edward Clark Keystone ; Alexander K. So ; Jürgen Braun ; Ferry C. Breedveld ; Gerd R. Burmester ; Fabrizio De Benedetti ; Thomas Dörner ; Paul Emery ; Roy Fleischmann ; Allan Gibofsky ; J R Kalden ; Arthur Kavanaugh ; Bruce Kirkham ; Philip Mease ; A. Rubbert-Roth ; Joachim Sieper ; Nora G. Singer ; Josef S. Smolen ; Piet L C M. Van Riel ; Michael H. Weisman ; Kevin L. Winthrop	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
001461 (2013)	Matthew L. Stoll [États-Unis] ; Randy Q. Cron	Treatment of juvenile idiopathic arthritis in the biologic age.
001494 (2013)	Gerdien Mijnheer [Pays-Bas] ; Berent J. Prakken ; Femke Van Wijk	The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics.
001517 (2013)	Meliha Crnkic Kapetanovic ; Tore Saxne ; Göran Jönsson ; Lennart Truedsson ; Pierre Geborek	Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
001518 (2013)	R J Maneiro [Espagne] ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-Reino	Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis.
001548 (2013)	Muriel Elhai [France] ; Marine Meunier ; Marco Matucci-Cerinic ; Britta Maurer ; Gabriela Riemekasten ; Tifenn Leturcq ; Raffaele Pellerito ; Carlos Alberto Von Mühlen ; Alessandra Vacca ; Paolo Airo ; Francesca Bartoli ; Ginevra Fiori ; Maria Bokarewa ; Valeria Riccieri ; Mike Becker ; Jérôme Avouac ; Ulf Müller-Ladner ; Oliver Distler ; Yannick Allanore	Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
001574 (2013)	Kristine E. Day [États-Unis] ; Lauren N. Beck ; C Hope Heath ; Conway C. Huang ; Kurt R. Zinn ; Eben L. Rosenthal	Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Immunoconjugates" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Immunoconjugates" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Immunoconjugates
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021